Comorbidity groups
| Comorbidity | Fields | Number | % | |
| Neuropathy | 652.761 8.5% | Cardiovascular tests if “P”* | 5.037 | 0.1 |
| EMG (electromyography) if “P”* | 21.218 | 0.3 | ||
| Mononeuropathy | 5.843 | 0.1 | ||
| Polyneuropathy | 480.685 | 6.2 | ||
| Autonomic neuropathy | 26.898 | 0.3 | ||
| Peripheral sensitivity test if “P”* | 112.116 | 1.5 | ||
| Heart failure | 317.479 4.1% | Echocardiography if “P”* | 87.194 | 1.1 |
| Heart failure | 117.774 | 1.5 | ||
| Left ventricular hypertrophy | 352 | Ventricular hypertrophy | 352 | 0.0 |
| Coronary heart disease | 837.238 10.8% | Stress test if “P”* | 5.250 | 0.1 |
| Coronarography if “P”* | 10.542 | 0.1 | ||
| Ischemic heart disease | 507.305 | 6.6 | ||
| Angina | 91.880 | 1.2 | ||
| Acute Myocardial Infarction | 152.899 | 2.0 | ||
| Coronary angioplasty | 275.406 | 3.6 | ||
| By-pass coronary | 167.878 | 2.2 | ||
| Background diabetic retinopathy | 1071.177 13,9% | Direct ophthalmoscopy if “P”* | 250.376 | 3.2 |
| Retinography if “P”* | 35.912 | 0.5 | ||
| Non-proliferating retinopathy | 829.368 | 10.7 | ||
| Advanced diabetic retinopathy | 330.355 4.3% | Fluoroangiography if “P”* | 36.826 | 0.5 |
| Proliferating retinopathy | 153.896 | 2.0 | ||
| Laser treated diabetic retinopathy | 100.877 | 1.3 | ||
| Maculopathy | 3.137 | 0.0 | ||
| Blindness | 26.606 | 0.3 | ||
| Diabetic foot | 127.807 1.7% | Trophic injury (ulcer) | 55.985 | 0.7 |
| Past trophic injury | 54.797 | 0.7 | ||
| Osteomyelitis | 446 | 0.0 | ||
| Soft tissue infection | 417 | 0.0 | ||
| Amputation | 40.620 0.5% | Major amputation (not traumatic) | 9.400 | 0.1 |
| Minor amputation (not traumatic) | 32.954 | 0.4 | ||
| Peripheral arteriopathy | 641.314 8.3% | Lower limbs arteriopathy | 532.441 | 6.9 |
| Lower limbs ecocolordoppler if “P”* | 85.555 | 1.1 | ||
| Lower limbs arteriography if “P”* | 5.631 | 0.1 | ||
| Lower limbs angioplasty | 824 | 0.0 | ||
| Peripheral by-pass | 23.431 | 0.3 | ||
| ABI (ankle/arm pressure index) | 64.872 | 0.8 | ||
| Nephropathy | 760.093 9.8% | Incipient nephropathy | 647.650 | 8.4 |
| Overt nephropathy | 184.152 | 2.4 | ||
| Nephrotic syndrome | 413 | 0.0 | ||
| Renal failure | 1493.312 19.3% | Chronic renal failure | 428.276 | 5.5 |
| Chronic renal failure | 1400.368 | 18.1 | ||
| Dialysis | 13.357 | Dialysis | 13.357 | 0.2 |
| Stroke | 253.166 3.3% | Transient ischemic attack | 81.113 | 1.1 |
| Stroke | 181.824 | 2.4 | ||
| Hypertension | 4631.376 60.0% | Arterial hypertension | 2161.945 | 28.0 |
| Hypertensive retinopathy | 527.880 | 6.8 | ||
| Prescription hypertensive drugs | 4201.454 | 54.4 | ||
| Dyslipidemia | 3324.970 43.1% | Hypercholesterolemia | 10.496 | 0.1 |
| Hypertriglyceridemia | 688 | 0.0 | ||
| Prescription lipid-lowering drugs | 3309.770 | 42.9 | ||
| Uricemia | 554.970 | Uricemia ≥8 | 156.592 | 2.0 |
| Liver disease (if at least 2 of the conditions) | 1332.682 17.3% | AST>30 U/L | 526.808 | 6.8 |
| ALT>36 U/L | 645.248 | 8.4 | ||
| Platelets<150.000 per microliter | 117.767 | 1.5 | ||
| GGT >50 U/L | 520.128 | 6.7 | ||
| Albuminuria (if at least 1 of the conditions) | 1733.794 22.5% | AER albumin excretion rate>20 mg/g | 9.252 | 0.1 |
| UACR >2.5 and male | 157.468 | 2.0 | ||
| UACR >3.5 and female | 89.936 | 1.2 | ||
| MAU microalbuminuria >30 mg7g | 568.486 | 7.4 | ||
*if “P”=if Positive.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma glutamil gransferase.